Literature DB >> 4511918

Syngeneic immune serum specifically inhibits the motility of tumour cells.

G A Currie, G C Sime.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4511918     DOI： 10.1038/newbio241284a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  5 in total

1.  Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.

Authors:  F K Stevenson; E V Elliott; G T Stevenson
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

2.  Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.

Authors:  D W Hough; R P Eady; T J Hamblin; F K Stevenson; G T Stevenson
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

3.  Immunity as the predominant factor determining metastasis by murine lymphomas.

Authors:  G C Davey; G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

4.  Cross reactivity of an alloantigen present on normal cells with the tumour-specific transplantation-type antigen of the acute myeloid leukaemia (SAL) of rats.

Authors:  A B Wrathmell; C L Gauci; P Alexander
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

5.  Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.

Authors:  C Basham; G A Currie
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.